Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q2 2025 · 10-Q
Revenue$7.93M$7.93M−1.4% vs Q2 2024 Net Income$355.79K$355.79K−45.7% vs Q2 2024 EPS Diluted$0.04$0.04−50.0% vs Q2 2024 Operating Income$1,492,634+7.3% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$644,606+2,891.3% Margins · derivedOperating margin18.8%+1.5 pt vs Q2 2024
Net margin4.5%−3.7 pt vs Q2 2024
ended May 31, 2025 · filed Jul 15, 2025 · 45 d after period end